Kaunas, Lithuania, 2011-09-20 15:02 CEST (GLOBE NEWSWIRE) -- On 20 September 2011 AB SANITAS received the notification of Valeant Pharmaceuticals International, Inc. on the acquisition of voting rights. The threshold that was crossed – 95%, the reason for crossing the threshold – purchase of shares during the implementation of the mandatory non-competitive tender offer to buy the remaining voting shares in the company.
Enclosed: Announcement on the acquisition of voting rights.
A person authorized to provide additional information: Mr. Saulius Jurgelenas, Chief Executive Officer of AB SANITAS phone number +370 686 67779.
Lawyer
Dovile Morkyte
+370 615 15163
